Cancer Research · 2018 · 26 citations · 41 references
Life SciencesHematologyMolecular BiologyDna RepairRadiobiologyStem Cell BiologyDna DamageDna Double-strand Break RepairDna Repair DefectsDna Strand BreaksDouble-strand Break RepairMyelodysplastic SyndromesDefective Dna Repair PathwaysDna Repair KineticsDna Repair Pathway DefectsDouble-strand Break MisrepairImpaired Dna RepairRepair Of Ionizing Radiation-induced BreaksSomatic MutationsTelomere Fragility
Abstract Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by blood cytopenias that occur as a result of somatic mutations in hematopoietic stem cells (HSC). MDS leads to ineffective hematopoiesis, and as many as 30% of patients progress to acute myeloid leukemia (AML). The mechanisms by which mutations accumulate in HSC during aging remain poorly understood. Here we identify a novel role for MYBL2 in DNA double-strand break (DSB) repair in HSC. In patients with MDS, low MYBL2 levels associated with and preceded transcriptional deregulation of DNA repair genes. Stem/progenitor cells from these patients display dysfunctional DSB repair kinetics after exposure to ionizing radiation (IR). Haploinsufficiency of Mybl2 in mice also led to a defect in the repair of DSBs induced by IR in HSC and was characterized by unsustained phosphorylation of the ATM substrate KAP1 and telomere fragility. Our study identifies MYBL2 as a crucial regulator of DSB repair and identifies MYBL2 expression levels as a potential biomarker to predict cellular response to genotoxic treatments in MDS and to identify patients with defects in DNA repair. Such patients with worse prognosis may require a different therapeutic regimen to prevent progression to AML. Significance: These findings suggest MYBL2 levels may be used as a biological biomarker to determine the DNA repair capacity of hematopoietic stem cells from patients with MDS and as a clinical biomarker to inform decisions regarding patient selection for treatments that target DNA repair. Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/20/5767/F1.large.jpg. Cancer Res; 78(20); 5767–79. ©2018 AACR.
41
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma, Rafael Bejar, Siddhartha Jaiswal et al. · Blood · 2015 · 1.9K citations · Full text
Medicine, Hematology, Pathology +16
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie, Charles Lu, Jiayin Wang et al. · Nature Medicine · 2014 · 1.9K citations · Full text
Medicine, Genetics, Hematology +14
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age
Derrick J. Rossi, David Bryder, Jun Seita et al. · Nature · 2007 · 1.1K citations